https://www.benzinga.com/news/earnings/22/02/25793346/recap-biomarin-pharmaceutical-q4-earnings
Biomarin Pharmaceutical (NASDAQ:BMRN) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about...
biomarin pharmaceuticalrecapearningsnasdaqbmrn
https://www.finanznachrichten.de/nachrichten-2026-01/67388672-veeva-systems-expands-long-term-partnership-with-biomarin-pharmaceutical-020.htm
WASHINGTON (dpa-AFX) - Veeva Systems Inc. (VEEV) and BioMarin Pharmaceutical Inc. (BMRN) on Thursday announced a long-term enterprise agreement that extends...
veeva systemslong termbiomarin pharmaceuticalexpandspartnership
https://247wallst.com/investing/2014/11/10/top-analyst-upgrades-and-downgrades-biomarin-bp-genworth-petrobras-target-and-more/
Monday's top analyst upgrades, downgrades and initiations include BioMarin Pharmaceutical, BP, Home Depot, Petrobras and Target.
topanalystupgradesdowngradesbiomarin
https://www.law360.com/healthcare-authority/articles/2424072/biomarin-inks-4-8b-amicus-buy-as-patent-litigation-resolved
BioMarin Pharmaceutical Inc. has agreed to acquire Amicus Therapeutics for $4.8 billion, in a deal bolstered by Amicus' settlement of patent litigation that...
patent litigationbiomarininksamicusbuy
https://www.statnews.com/2025/12/19/biomarin-amicus-acquisition-rare-disease-fabry-pompe/
Dec 19, 2025 - The deal, a major step for BioMarin's CEO, will bring a number of rare disease therapies under the company's roof.
rare diseasebiomarinbuyfocusedamicus
https://www.mediabistro.com/jobs/1272367927-biomarin-is-hiring-associate-director-clinical-medical-writing-in-san-rafael
Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science to tra...
medical writingbiomarinhiringassociatedirector
https://www.omicsonline.org/universities/BioMarin/
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United .. .
biomarin